Can Human Cytomegalovirus Infections Spark Alzheimer’s Pathology?
In postmortem tissue, nearly half of AD patients had HCMV infections in the brain and gut. In cerebral organoids, HCMV triggered accumulation of Aβ and p-tau212.
6534 RESULTS
Sort By:
In postmortem tissue, nearly half of AD patients had HCMV infections in the brain and gut. In cerebral organoids, HCMV triggered accumulation of Aβ and p-tau212.
This coupling erodes with age, making synapses sluggish. Rekindling the connection counteracts synaptic deficits and memory loss in old mice.
Scott Small offers a closing argument.
Dennis Selkoe replies to Scott Small.
Scott Small reacts to a recent perspective paper and the discussion it engendered.
In mice, crippling PSEN2 worsened amyloid deposition, synaptic dysfunction, and deficit in working memory.
A Tolstoy-inspired method identifies AD variants that exert similar effects, pinpointing causal AD proteins—six known, plus a new one, RET.
As levels of the deacetylase wane with age, more APP gets processed in endosomes, worsening amyloid pathology.
Report probes predictors of dementia, the benefits of early detection, and people’s motivation to seek testing and treatment.
Lipids, amino acids, carbohydrates, and other molecules in the CNS linked to genetic variants, some of which upped the risk for neurodegenerative disease.
Eight proteins in blood associate with faster brain aging, five with slower. The extracellular matrix protein brevican comes with larger cortical volume, lower dementia odds.
Study correlated AD genome-wide association with concentrations of 6,000 CSF proteins to find potential disease variants.
In plaque- and tangle-laden layers of the Down’s syndrome neocortex, neuroinflammation raged, and glia sent death signals to neurons.
After symptoms of autosomal-dominant AD start, the uptick in neurofilament light chain accelerates in CSF but tapers in plasma.
Opinion leaders argue that the field’s knowledge base is now strong enough for regulators to greenlight amyloid-removing immunotherapies without evidence on cognitive/clinical outcomes.
No filters selected